TAmiRNA is dedicated to supporting researchers and clinicians in RNA biomarker discovery, validation, and development. Our mission is to provide innovative diagnostic solutions that improve patient outcomes, with a focus on precision medicine and age-associated diseases.

We specialize in biomarker discovery using cell-free RNAs, including microRNAs, mRNAs, and long non-coding RNAs (lncRNAs). By integrating RNA signatures with AI-driven analysis, we develop actionable diagnostic solutions that enhance disease detection and patient stratification.

TAmiRNA drives R&D and contract research in liver disease, senescence, cardiovascular disease, oncology, and bone and joint disorders. Using advanced transcriptomic approaches, we aim to decode disease mechanisms, personalize diagnostics, and accelerate biomarker-driven innovations.